1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1. Objective of the
Study
2.2. Baseline Methodology
2.3. Key Industry
Partners
2.4. Major Association
and Secondary Sources
2.5. Forecasting
Methodology
2.6. Data Triangulation
& Validation
2.7. Assumptions and
Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, and Trends
4.
Voice of Customer
5. Global Connected
Drug Delivery Devices Market Outlook
5.1.
Market Size & Forecast
5.1.1. By Value
5.2.
Market Share & Forecast
5.2.1. By Product Type (Connected Sensors v/s Integrated Connected Devices)
5.2.2. By Technology (Bluetooth, Near Field Communication, Others)
5.2.3. By Application (Asthma & COPD, Diabetes, Others)
5.2.4. By End User (Healthcare Providers v/s Homecare)
5.2.5. By Company (2021)
5.2.6. By Region
5.3.
Product Market Map
6. Asia-Pacific Connected
Drug Delivery Devices Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Technology
6.2.3. By Application
6.2.4. By End User
6.2.5. By Country
6.3.
Asia-Pacific: Country Analysis
6.3.1. China Connected Drug
Delivery Devices Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Product Type
6.3.1.2.2.
By Technology
6.3.1.2.3.
By Application
6.3.1.2.4.
By End User
6.3.2. India Connected Drug
Delivery Devices Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Product Type
6.3.2.2.2.
By Technology
6.3.2.2.3.
By Application
6.3.2.2.4.
By End User
6.3.3. South Korea Connected
Drug Delivery Devices Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Product Type
6.3.3.2.2.
By Technology
6.3.3.2.3.
By Application
6.3.3.2.4.
By End User
6.3.4. Japan Connected Drug
Delivery Devices Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Product Type
6.3.4.2.2.
By Technology
6.3.4.2.3.
By Application
6.3.4.2.4.
By End User
6.3.5. Australia Connected
Drug Delivery Devices Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Product Type
6.3.5.2.2.
By Technology
6.3.5.2.3.
By Application
6.3.5.2.4.
By End User
7. Europe Connected
Drug Delivery Devices Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Technology
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.3.
Europe: Country Analysis
7.3.1. France Connected
Drug Delivery Devices Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product Type
7.3.1.2.2.
By Technology
7.3.1.2.3.
By Application
7.3.1.2.4.
By End User
7.3.2. Germany Connected
Drug Delivery Devices Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product Type
7.3.2.2.2.
By Technology
7.3.2.2.3.
By Application
7.3.2.2.4.
By End User
7.3.3. United Kingdom Connected
Drug Delivery Devices Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product Type
7.3.3.2.2.
By Technology
7.3.3.2.3.
By Application
7.3.3.2.4.
By End User
7.3.4. Italy Connected Drug
Delivery Devices Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Product Type
7.3.4.2.2.
By Technology
7.3.4.2.3.
By Application
7.3.4.2.4.
By End User
7.3.5. Spain Connected Drug
Delivery Devices Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Product Type
7.3.5.2.2.
By Technology
7.3.5.2.3.
By Application
7.3.5.2.4.
By End User
8. North America Connected
Drug Delivery Devices Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Technology
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.3.
North America: Country Analysis
8.3.1. United States Connected
Drug Delivery Devices Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product Type
8.3.1.2.2.
By Technology
8.3.1.2.3.
By Application
8.3.1.2.4.
By End User
8.3.2. Mexico Connected
Drug Delivery Devices Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product Type
8.3.2.2.2.
By Technology
8.3.2.2.3.
By Application
8.3.2.2.4.
By End User
8.3.3. Canada Connected
Drug Delivery Devices Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product Type
8.3.3.2.2.
By Technology
8.3.3.2.3.
By Application
8.3.3.2.4.
By End User
9. South America Connected
Drug Delivery Devices Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Technology
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country
9.3.
South America: Country Analysis
9.3.1. Brazil Connected
Drug Delivery Devices Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product Type
9.3.1.2.2.
By Technology
9.3.1.2.3.
By Application
9.3.1.2.4.
By End User
9.3.2. Argentina Connected
Drug Delivery Devices Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product Type
9.3.2.2.2.
By Technology
9.3.2.2.3.
By Application
9.3.2.2.4.
By End User
9.3.3. Colombia Connected
Drug Delivery Devices Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product Type
9.3.3.2.2.
By Technology
9.3.3.2.3.
By Application
9.3.3.2.4.
By End User
10. Middle East and
Africa Connected Drug Delivery Devices Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Technology
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country
10.3.
MEA: Country Analysis
10.3.1. South Africa Connected
Drug Delivery Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Product Type
10.3.1.2.2.
By Technology
10.3.1.2.3.
By Application
10.3.1.2.4.
By End User
10.3.2. Saudi Arabia Connected
Drug Delivery Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Product Type
10.3.2.2.2.
By Technology
10.3.2.2.3.
By Application
10.3.2.2.4.
By End User
10.3.3. UAE Connected Drug
Delivery Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Product Type
10.3.3.2.2.
By Technology
10.3.3.2.3.
By Application
10.3.3.2.4.
By End User
10.3.4. Kuwait Connected
Drug Delivery Devices Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1.
By Product Type
10.3.4.2.2.
By Technology
10.3.4.2.3.
By Application
10.3.4.2.4.
By End User
11.
Market Dynamics
11.1.
Drivers
11.1.1. Rapidly Moving
Healthcare IT Infrastructure
11.1.2. Rising Adoption of
Machine Learning
11.2.
Challenges
11.2.1. High Price of
Devices
11.2.2. Security concerns
related to patient data
12.
Market Trends & Developments
13.
Clinical Trial Analysis
14.
Competitive Landscape
14.1.
Abbott Laboratories, Inc.
14.1.1. Business Overview
14.1.2. Product Offerings
14.1.3. Recent Developments
14.1.4. Financials (In Case
of Listed Companies)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2.
Reciprocal Labs Corporation (Propeller Health)
14.3.
F. Hoffmann-La Roche Ltd.
14.4.
Teva Pharmaceutical Industries Ltd.
14.5.
Biocorp Production SA
14.6.
Merck KGaA
14.7.
Adherium Ltd
14.8.
West Pharmaceutical Services, Inc.
14.9.
Aterica Digital Health
14.10.
Molex LLC (Phillips Medisize)
14.11.
Cohero Health, Inc.
14.12.
Elcam Medical ACS. Ltd
14.13.
Becton, Dickinson, and Company
14.14.
Ypsomed Holding AG
14.15.
Unilife Corporation
15. Strategic Recommendations
About Us & Disclaimer